Drug Approval | May 13, 2024
Zydus receives final approval from USFDA for Dexamethasone Tablets
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Subscribe To Our Newsletter & Stay Updated
